Literature DB >> 9667079

Effect of interleukin 1 beta-induced fever on hepatic drug metabolism in rat.

T Kihara1, A Toda, I Umesue, N Ono, H Shigematsu, S Soeda, H Shimeno.   

Abstract

1. A fever-induced model in rat was created by repeated injection of interleukin 1 beta (IL-1 beta) in the cerebroventricle and the influence of fever on hepatic drug metabolism was investigated. Fever apparently decreased the content of cytochrome P450 (CYP) and the activities of NADPH-ferrihaemoprotein reductase (fp2), aminopyrine N-demethylase, aniline hydroxylase, FAD-monooxygenase, p-nitrophenol UDP-glucuronosyl-transferase and glutathione S-transferase. Immunoblot analysis of the CYP isozymes indicated that CYP2C11 and CYP3A were extensively decreased in the IL-1 beta-induced fevered rat. 2. Repeated administration (5 days) of mefenamic acid in the fevered rat could not restore the activities of fp2, aminopyrine N-demethylase and aniline hydroxylase to control levels, although their hyperthermic state had been improved. The CYP content in the mefenamic acid-treated fevered rat was also lower than that in the control. 3. These findings suggest that fever impairs the hepatic drug-metabolizing capacity (both oxidation and some conjugations) and that the fever-induced impairments are partially retained, even if the hyperthermia has been offset by the administration of antipyretics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667079     DOI: 10.1080/004982598239317

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells.

Authors:  S N Lavergne; H Wang; H E Callan; B K Park; D J Naisbitt
Journal:  J Pharmacol Exp Ther       Date:  2009-08-07       Impact factor: 4.030

2.  Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers.

Authors:  James S McCarthy; Mark Baker; Peter O'Rourke; Louise Marquart; Paul Griffin; Rob Hooft van Huijsduijnen; Jörg J Möhrle
Journal:  J Antimicrob Chemother       Date:  2016-06-05       Impact factor: 5.790

3.  Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients.

Authors:  Pierre-Jean Ferron; Brendan Le Daré; Julie Bronsard; Clara Steichen; Elodie Babina; Romain Pelletier; Thierry Hauet; Isabelle Morel; Karin Tarte; Florian Reizine; Bruno Clément; Bernard Fromenty; Thomas Gicquel
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

Review 4.  The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy.

Authors:  Guyi Wang; Bing Xiao; Jiayi Deng; Linmei Gong; Yi Li; Jinxiu Li; Yanjun Zhong
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.